Mort has more than 40 years of experience advising clients on mergers and acquisitions and related deals. He has represented acquirers, targets, investment bankers and investors across a number of industry sectors, including financial services, healthcare, media, entertainment and telecommunications.
Adept at leading clients through the various stages of highly complex transactions, Mort has been involved in numerous high-profile deals, involving some of the world's best known companies. These transactions include the acquisitions of EMI Music Publishing and MGM by Sony, the acquisition of CNET by CBS, the acquisitions of Capital Cities/ABC, Fox Family, Pixar and Marvel by The Walt Disney Company, the acquisition of The MONY Group by AXA Financial, and the Wells Fargo acquisition of First Interstate Bank.
Mort also has experience of numerous cross-border and multi-jurisdictional merger and acquisition transactions. These include the acquisition of GTECH by Lottomatica, the Zimmer Holdings acquisition of Centerpulse AG, the Guinness/GrandMet merger, the Luxottica Group S.p.A. acquisition of The United States Shoe Corporation and the Cable & Wireless acquisition of NYNEX CableComms.
Mort is listed as a "Leading Individual" for M&A in the United States by Euromoney (2020).
Mort received his JD from the University Of Pennsylvania Law School in 1974. He attended the University of Oxford from 1974–1975, and received his BA from Yale University in 1970.
Mort has been recognized numerous times as a leader in the fields of mergers and acquisitions and corporate governance, including in Chambers Global (2020), Chambers USA (2020), The Legal 500 US (2020), Euromoney (2020) and Best Lawyers (2020).
Recent matters include the representation of:
- Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, in its acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.
- Sony Corporation of America in its approximately US$400 million investment in Bilibili Inc., a China-based provider of online entertainment services.
- LifePoint Health, Inc. (NASDAQ: LPNT) in its US$5.6 billion merger with fellow healthcare provider RCCH HealthCare Partners (RCCH), which was owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO);
- Calpine Corporation in its US$17 billion sale to Energy Capital Partners, an energy-focused private equity firm, and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board;
- Zimmer Holdings, Inc. (NYSE/SIX: ZMH), a world leader in musculoskeletal health solutions, in its US$13.35 billion acquisition of Biomet, Inc., one of the world's leading medical device manufacturers.
- The special committee of the board of directors of Cellular Biomedicine Group, Inc. (CBMG), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, in connection with CBMG's definitive merger agreement to be acquired by a consortium of international investors.